Sunday 18 October 2026
Export FENC’s income statement to Excel — free account
Adherex Technologies Inc.
FENC Healthcare Biotechnology
Adherex Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 million, down 6.09% from fiscal 2024. In the quarter to June 2026, revenue grew 85.2%, EPS grew 154.6% and free cash flow grew 101.4%, each against the same quarter a year earlier.
9.98
0.37
−3.57%
Follow FENC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 1 | 1 |
+8 more TTM periods Free account |
| (18.58%) | (52.68%) | (65.82%) | 143.64% | ||
| (5.39%) | (14.17%) | (16.87%) | (12.83%) | ||
ROIC |
(58.89%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(5.41%) | (14.62%) | (17.23%) | (19.15%) | |
Average Days of Receivables |
143.40 | 134.28 | 189.86 | 182.01 | |
Free Cash Flow per Share |
(0.06) | (0.17) | (0.44) | (0.29) | |
Free Cash Flow |
(2.04) | (5.78) | (12.47) | (7.98) | |
| Other line items | |||||
Cash ROIC |
(2.44%) | (7.42%) | (17.26%) | (22.45%) | |
Accounts Receivable Turnover |
2.91 | 2.98 | 2.47 | 2.41 | |
Accounts Payable Turnover |
0.65 | 0.69 | 0.96 | 0.55 | |
Inventory Turnover |
1.62 | 2.43 | 2.87 | 1.48 | |
Average Days of Payables |
541.95 | 578.78 | 449.46 | 802.21 | |
Days of Inventory on Hand |
233.25 | 171.03 | 151.76 | 338.74 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.36% | 0.40% | 0.56% | 0.72% | |
Selling, General and Administrative Expense of Revenue |
95.26% | 102.80% | 105.08% | 104.42% | |
Share Based Compensation of Revenue |
12.67% | 14.17% | 15.75% | 14.53% | |
Interest Coverage |
(1.24) | (3.74) | (3.02) | (1.70) | |
Operating CF/Net income |
0.63 | 0.69 | 1.28 | 1.15 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.71 | 1.49 | 1.56 | 1.39 | |
Operating CF per Share |
(0.06) | (0.17) | (0.44) | (0.29) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates